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Abstract 
A ca. 45-kDa protein which was recently identified and purified to homogeneity from a solid tumor cell line as a T-cell mitogen was 
found to have significant sequence similarities with human monocyte/neutrophil elastase inhibitor (EI) [l]. Since EI is a known substrate 
for elastase, a determination f whether a cell surface xpressed elastase-like molecule might be the binding protein for this 45-kDa factor 
and mediate mitogenic signal transduction was undertaken. First, the surface of tumor infiltrating lymphocytes, TIL 660, the indicator cell 
line used for the purification of this mitogen, was shown to stain positively with an anti-elastase antibody using flow cytofluorometry for 
quantitation. Then, after observing an inverse correlation between cell surface staining and the proliferative status of the TILs, behavior 
which might be expected of a growth factor receptor upon activation, mitogenic signal transduction was attempted through the 
elastase-like molecules of the lymphocytes' plasma membrane with the anti-elastase antibody in the role of mitogen. A greater than 4-fold 
mitogenic stimulation was observed when this antibody was covalently linked to latex beads; in contrast, addition of the soluble form of 
the same antibody did not result in any increase in [3H]thymidine incorporation i to the cells' DNA. Hence, these data support induced 
clustering of an elastase-like molecule on the lymphocyte surface as a mediator of mitogenesis and suggest hat the binding protein for 
mitogenic signal transduction i duced by the 45-kDa protein, a member of the serine protease inhibitor (serpin) superfamily of proteins, is 
a molecule with structure similar to a serine protease. 
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1. Introduction 
The concept of an imrnunosurveillance n twork which 
is composed of cells of lymphoid and myeloid origin 
circulating in search of aberrant cells as targets has led to 
the development of several clinical trial protocols for the 
treatment of cancer as well as for a number of infectious 
diseases [2-5]. Since the immune system was thought o 
be suboptimal in all of the above studies, functional aug- 
mentation was attempted by at least one of several ap- 
proaches, e.g., the introduction of biologic response modi- 
fiers such as interferons, interleukins, and colony stimulat- 
ing factors [6,7], the use of antibodies against molecules 
Abbreviations: TIL, tumor infiltrating lymphocyte; EI, human mono- 
cyte/neutrophil elastase inhibitor; SFM, serum-free medium; PBS, phos- 
phate-buffered saline; hLEI, human leukocyte lastase inhibitor. 
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expressed on target cell surfaces in large quantities or at 
unusual sites [8-10], and the ex vivo activation and/or 
amplification of immunocytes such as NK/LAK cells and 
T-lymphocytes by cytokines and/or surface antigens of 
target cells [l 1,12]. Although some successes have been 
achieved with these approaches, many of which used 
immunostimulants rarely found at detectable l vels in the 
tumor environment in vivo, the results have not led to a 
deep understanding of the immunosurveillance n twork. 
Our work has been directed toward defining im- 
munomodulatory factors which tumor cells produce. By so 
doing, we hope first to define the essential components of 
the local tumor immunosurveillance n twork and eventu- 
ally to use this information to formulate an effective 
immunotherapy against cancer. To this end, we have re- 
cently identified, purified to homogeneity, and obtained 
partial sequences for two proteins, Oncoimmunin-L, a 
45-kDa protein which stimulates mitogenesis in human 
tumor infiltrating lymphocytes (TILs) in culture [l], and 
Oncoimmunin-M, a 36 kDa protein which induces differ- 
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entiation/activation markers in a preterminally differenti- 
ated myeloid cell line [13,14]. 
Since the 45-kDa protein has been shown by amino acid 
sequence analysis of 7 tryptic fragments to have at least 
31% sequence identity with human monocyte/neutrophil 
elastase inhibitor (El) and the latter is a known substrate 
for elastase, in order to determine a possible mechanism of 
action for our purified T-cell mitogen, the surface of the 
indicator cell line used during the purification was exam- 
ined for expression of an elastase-like molecule. After 
measuring its expression level with an anti-elastase anti- 
body on the 660 TIL surface, a study was undertaken to 
determine a possible role for a T-cell-associated lastase in 
mitogenic signal transduction. 
2. Materials and methods 
2.1. Materials 
Dulbecco's modified Eagle's, Ham's F-12, and AIM-V 
med ia  were  purchased  f rom GIBCO;  
N H2-~',,,,,,.~....,,J -NH 2 
+ 
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Fig. 1. Reaction scheme for the derivatization of amino-latex beads. The carbohydrate r sidues (depicted as dotted ovals in the right-hand side part of the 
figure) in the F c domain of the IgGs were oxidized with NalO 4 to generate dialdehydes which were then reacted with cystamine to form Schiff bases; the 
disulfide bonds of the latter were then reduced with 2-mercaptoethanol. The oxidized and reduced IgGs were subsequently cross-linked to the bead surface 
via the heterobifunctional gent sulfo-MBS. Each bead contained 1.52 × 10-17 mol of amino groups and the starting concentration was 6.85 × 10 -7 
amino groups per ml (4.5 X 10 I° beads per ml). 
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insulin/transferrin/sodium selenite medium supplement, 
cystamine, 2-mercaptoethanol, and donkey anti-sheep 
IgG-FITC from Sigma Chemicals; [3H]thymidine (6.7 
Ci/mmol; 1 Ci = 37 GBq) from Du Pont-New England 
Nuclear; sulfo-MBS, G25 columns, and sodium periodate 
from Pierce Chemicals; sheep anti-elastase and sheep anti- 
human immunoglobulin-G from ICN; and 1 /zm diameter 
amine-modified latex beads (L-5391) from Molecular 
Probes. 
The human T-lymphocyte line, 660 TIL, was estab- 
lished from a human melanoma tumor as described previ- 
ously [15]. 
2.2. Methods 
ies described above was then added to each tube. Follow- 
ing a 32-h incubation at room temperature on a rotator, the 
suspension was washed three times with phosphate- 
buffered saline and then irradiated (10 krad) (1 rad = O.O1 
Gy). 
Cellular proliferation assays. Approximately 48 h pre- 
ceding the commencement of proliferation assays, cells 
were washed twice with and then cultured in SFM. 
[3 H]Thymidine incorporation assays as a measure of cellu- 
lar proliferation in which the final cell concentration was 
6 X 105 cells/ml were performed in quintuplicate in 96- 
well flat-bottomed plates as described previously [15], with 
replacement of SFM with equivalent volume of SFM 
containing beads (65 A) to each well. 
Culturing. The human T-lymphocyte line (660 TIL) 
was carried in AIM-V medium supplemented with 1 X 103 
Cetus U of IL-2 per ml. All bioassays were performed in a 
serum-free medium (SFM), the composition of which was 
a 1:1 mixture of Dulbecco's modified Eagle's medium (4.5 
g of glucose/liter) and Ham's F-12 supplemented with 
insulin, transferrin, and sodium selenite at 5 /xg/ml, 5 
/zg/ml, and 5 ng/ml, respectively. 
Flow cytometery. All staining was carried out at 4°C in 
phosphate-buffered saline containing 10% fetal calf serum 
and 0.02% (w/v)  NaN 3 for 45-60 rain; 0.5-1.0 X 10 6 
cells were used per sample. Data were acquired using a 
Becton-Dickinson FACScan instrument and only cells 
which took up propidium iodide were gated out. 
Labeling of heads. For each synthesis the quantity of 
approximately 20 nmol of sheep anti-human IgG was 
covalently coupled to 1.0 mm amine-modified latex beads 
via the bifunctional cross-linking agent sulfo-MBS using 
the following procedure (Fig. 1): buffers for antibodies 
were exchanged such that ~:he starting concentration f IgG 
was 20 nmol per 0.5-1.0 ml of 0.1 M sodium phosphate 
buffer (pH 7.0). To this solution was added 5 mg (2.3 X 
10 -s mole) sodium periodate. After 1 h at 35°C the 
reaction mixture was chromatographed on a G-25 column 
and the carbohydrate-modified antibody eluted in the void 
volume fraction. To this solution 5 X 10 -6 mol of cys- 
tamine was then added; after 1 h an addition of 1 × 10 -s 
mol 2-mercaptoethanol was made to quench the unreacted 
aldehyde functional group on the carbohydrate moieties of 
the IgG. The antibody-containing solution was then loaded 
onto a G-25 column and eluted with 25 mM Tris (pH 7.5) 
to isolate the derivatized IgG from the low molecular 
weight reactants, i.e., cystamine and 2-mercaptoethanol. 
Five ml of the amine-modified latex beads containing 
3.42 X 10 -6 amine equivalents was exchanged with 25 
mM Tris (pH 7.5) by centrifugation at 3000 rpm for 30 
min. To this suspension sulfo-MBS (1.71 X 10 -s mole) 
was then added and it was placed on a rotator at room 
temperature for 1.5 h. The suspension was then centrifuged 
and the beads were washed with 10 ml of Tris buffer three 
times. The bead suspension of oxidized/reduced antibod- 
3. Results 
Initial experiments were aimed at ascertaining whether 
an elastase-like molecule was present on the 660 TIL 
surface. After flow cytofluorometry data indicated that 
such a molecule was a component of the plasma mem- 
brane, this study was directed towards determining a possi- 
ble functional role for a T-cell-associated lastase. Upon 
observing a small inverse correlation between anti-elastase 
surface binding and cell proliferation, mitogenic signal 
transduction was attempted by using the surface elastase 
molecule as binding protein and the soluble anti-elastase 
antibody as ligand. When this was unsuccessful, the same 
antibody was covalently bound to the surface of latex 
beads via the antibody's carbohydrate moieties through a 
heterobifunctional cross-linking agent (Fig. 1). This latter 
approach resulted in reproducible mitogenic stimulation of 
660 TILs as described below. 
In Fig. 2a comparison of histograms of 660 TILs stained 
with sheep anti-human IgG (control) followed by donkey 
anti-sheep-FITC (peak channel number, 6; mean channel 
number, 6) (top panel) versus sheep anti-human elastase 
IgG followed by donkey anti-sheep-FITC (peak, 237; mean, 
226) (bottom panel) indicates the presence of elastase on 
the TIL surface. 
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Fig. 2. Histograms of 660 TILs stained with (top) sheep anti-human IgG 
followed by donkey anti-sheep-FITC (peak channel number, 6; mean 
channel number, 6) and (bottom) sheep anti-human elastase followed by 
donkey anti-sheep-FITC (peak, 237; mean, 226). 
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Fig. 3. Histograms of 660 TILs stained with (a) Control antibodies (b) 
anti-CD13 (c) anti-CD26- and (d) anti-elastase. For anti-CD13 and anti- 
CD26, mouse anti-human isotype-matched monoclonal antibodies erved 
as contols and for anti-elastase, which was a sheep, anti-human IgG was 
used. 
Since elastase is best known as a protease and all cells 
are believed to contain some proteolytic activity on their 
surfaces [ 16], including those associated with several of the 
cluster of differentation (CD) antigens of lymphoid and 
myeloid cells, e.g., CD26 and CD13, resp. [17], the 660 
TIL surface was examined for the presence of these latter 
molecules. Histograms in Fig. 3 show the presence of 
CD26 and absence of CD13 on the surface of 660 TILs as 
well as a comparison with elastase. 
Whereas a molecule with sequence similarities to hu- 
man elastase inhibitor had been identified and purified to 
homogeneity as a T-cell mitogen [1] and the presence of 
elastase was measured on the surface of the indicator 
T-cell line used for the purification, i.e., 660 TILs, the 
expression level of the latter molecule on the 660 TIL 
surface was measured as a function of the proliferative 
state of these cells. Thus, elastase and CD26 levels on cells 
in both resting and proliferative states were measured by 
flow cytofluorometry. Data in Table 1 show that concomi- 
tant with proliferation an 11% decrease (from peak chan- 
nel number 199 to 177) in elastase xpression and a 4% 
increase (from channel number 232 to 241) in CD26 
Table 1 
Surface expression of two molecules with protease activity, i.e., elastase 
and CD26, as a function of proliferative status of 660 TILs 
Cell status a Elastase ot CD26 
(peak channel number) (peak channel number) 
Resting 196 232 
Proliferating 176 241 
Resting cells had been in serum-free medium in the absence of any 
mitogenic stimulus for at least 48 h, whereas proliferating cells had been 
cultured for a minimum of 10 h in the presence of a mitogen, e.g., IL-2 or 
the 45-kDa protein. Flow cytofluorometric data (peak channel numbers 
from a logarithmic scale) denote an 11% decrease in elastase xpression 
and a 4% increase in CD26 expression. 
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Fig. 4. Dose-response curve of the soluble anti-elastase antibody ([]) 
and control (sheep anti-human antibody (Sail)) (O) as measured by 
proliferation of 660 TILs. Stimulation with IL-2 served as the positive 
control. 
expression were induced. Since these data were measured 
on a logarithmic scale, the small 15% difference was 
considered to be significant. 
After it was found that the elastase level on the T-cells 
decreased as the proliferative rate increased, the question 
of whether cell surface elastase could play a role in 
mitogenic signal transduction in these cells was asked, 
using the anti-elastase antibody as ligand and the surface 
elastase molecules as binding protein. As displayed in Fig. 
4, no increase in proliferation was observed up to 2 × 10-8 
M antibody. 
In contrast, as shown in Fig. 5, when the anti-elastase 
antibody was presented to the cells at high local density on 
.m. 
E Q. 
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O) 
[] SFM 
[] 660 TILs 
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Fig. 5. A comparison of [3H]thymidine incorporation into the DNA of 
660 TILs in the presence and absence of latex beads covalently labeled 
with anti-elastase antibody. 
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the surface of latex beads (total solution concentration of
antibody was 1.25 X 10 -9 M), [3H]thymidine incorpora- 
tion was stimulated. Thus, proliferation data plotted in Fig. 
5 support a possible role for cell surface elastase as a 
mediator of mitogenic signal transduction i these cells. 
4. Discussion 
The concept of immunosurveillance suggests the exis- 
tence of a network of host cellular and molecular compo- 
nents capable of recognizing and eradicating foreign tar- 
gets; the immunosurveillance network theory predicts that 
a cancer cell should be recognized as aberrant and subse- 
quently destroyed by hosl: immune cells. Although im- 
munotherapeutic studies in which the objective has been 
the eradication of tumor masses using biologic response 
modifiers to augment putative suboptimal immune systems 
have shown some success., an understanding of the local 
tumor environment is far from clear [2-5]. One of the most 
perplexing questions concerns the presence of immuno- 
cytes at tumor sites as seen in histologic sections: if the 
immunocytes function as in vitro assays suggest, their 
presence points to a finite but suboptimal immune rep- 
sonse. 
In order to gain an understanding of the components of 
the local tumor environment, specifically the molecules 
with immunomodulatory a.ctivity which tumor cells pro- 
duce, we have been conce:med with identifying tumor-de- 
rived molecules capable of inducing mitogenesis, chemo- 
taxis, and differentiation of lymphoid and myeloid cells. 
To this end, we have identified, purified to homogeneity, 
and obtained partial sequences of two proteins with im- 
munomodulatory activities produced by an epidermal car- 
cinoma cell line [1,13]. One of these proteins, Oncoim- 
munin-L, a 45-kDa mitogen for human tumor infiltrating 
lymphocytes, has been shown to have at least 31% se- 
quence identity with the serine protease inhibitor, human 
monocyte/neutrophil elastase inhibitor (El) [1]. 
Inasmuch as the overall objective of our work is to 
understand how tumor cells communicate with compo- 
nents of the immunosurveillance n twork, e.g., lympho- 
cytes, we sought he binding and signal mediating protein 
on the T-cell which was used as a guide during the 
mitogen purification from the tumor cells. Since, as its 
name implies, El is a known substrate for elastase, the 660 
TIL surface was examined for the presence of the latter 
molecule. After observing: its expression, as defined by 
recognition by an anti-elastase antibody (Fig. 2), as well as 
that of another known lymphoid surface protease, i.e., 
CD26, (Fig. 3), a correlation between proliferative status 
of the lymphocytes and surface expression of these two 
nominal proteases was sought; data in Table 1 indicated a
small but significant (10.-15% on a logarithmic scale) 
decrease in elastase xpression whereas CD26 was virtu- 
ally unaffected (0-5%). Hence, as has been shown for 
growth factor receptors, i.e., down-regulation of a signal- 
transducing membrane glycoprotein, T-cell surface-associ- 
ated elastase xpression varied inversely as a function of 
the cellular proliferative state. These data suggested the 
question of whether this cell surface lastase-like molecule 
could mediate mitogenic signal transduction i  these T- 
cells. 
To this end direct mitogenic activation of the 660 TILs 
via the plasma membrane-associated elastase-like mole- 
cues was attempted via interaction with the soluble anti- 
elastase antibody. As data plotted in Fig. 4 indicate, mito- 
genic signal transduction was not achieved by this ap- 
proach. However, when the same antibody was covalently 
linked to latex beads via carbohydrate r sidues in the F c 
domain (Fig. 1), [ 3 H]thymidine incorporation i to the DNA 
of these cells was effected (Fig. 5). The lack of success 
with a soluble antibody compared with results obtained 
from the beads' experiment, where the same antibody was 
immobilized and at high local concentration, implies that 
mitogenic signal transduction by the surface lastase is not 
due to proteolytic activity generated by elastase. Further- 
more, the total concentration of antibody cannot be the 
critical factor since mitogenic signal transduction was not 
affected by the soluble antibody at concentrations upto 20 
nM, whereas, in beads' experiments, success was achieved 
with the concentration f anti-elastase atonly 1.25 nM. 
Elastase has most frequently been found to be produced 
by pancreatic cells [ 18], neutrophils [ 19], and macrophages 
[20] with differing characteristics depending on the cell of 
origin. Substrates include elastin, collagen, fibronectin, 
cartilage, proteoglycan, heparin, insulin, and Complement 
components C3, C5, C1 esterase inhibitor, and Factor B, in 
addition of IgG, kappa light chains [21] and CD4 [22]. 
Since this molecule had also been associated with a num- 
ber of immunologic disease states including rheumatoid 
arthritis, cystic fibrosis, and leukemia [21], the existence of 
a lymphocyte-associated elastase was not unexpected [23]. 
However, the role that elastase may play in the immune 
response is not clear. For example, a role as a protease was 
suggested by the close physical association of an elastase- 
like molecule with the T-cell receptor as evidenced by 
their copurification [24-27]. However, the lack of effect of 
elastolytic inhibition on immune responsiveness [27] sug- 
gested other mechanisms might be operating including a 
role as a substrate or a ligand unique to a specific immune 
response or class of responses. A similar dissociation 
between structure and function has been observed for 
scatter factor, also known as hepatocyte growth factor, 
which is a fibroblast-derived cytokine characterized by 
both its ability to convert non-motile pithelial cells to a 
motile fibroblast-like phenotype and as a broad-spectrum 
mitogen; this heterodimeric glycoprotien, although omol- 
ogous to plasminogen and other blood coagulation pro- 
teases, lacks proteolytic activity [28]. In contrast, coexpres- 
sion of human CD26 and CD4 in murine NIH-3T3 cells 
was reported to render them permissive to infection by 
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HIV-1 and HIV-2 virus entry which could be blocked by 
specific peptide inhibitors [29]; however, this proteolytic 
role for CD26 in HIV/cell fusion has since been ques- 
tioned [30-33] and readdressed [34]. 
Thus, it is unlikely that the mitogenic signal mediated 
by the plasma membrane-associated elastase that we are 
reporting is a result of the latter's proteolytic activity, 
particularly since neither we nor others (vide supra) have 
clearly demonstrated protease activity to be a property of 
T-cell surface elastase-like molecule. The trigger for the 
TILs' response appears to be the interaction between anti- 
elastase antibodies and cell surface lastase molecules with 
subsequent clustering of these complexes. Previously, sig- 
nal transduction i duced by antibodies against cell surface 
receptors has been reported, but usually the difference 
between success and failure has been most striking be- 
tween antibody mono- and bivalency [35,36]. In contrast, 
in the work described here, the bivalent antibody could not 
induce mitogenic signal transduction, whereas the polyva- 
lent beads could. Therefore, these data suggest that a fairly 
extensive global reorganization of components in the cell 
membrane [37] may be induced as immobilized anti-elas- 
tase antibodies interact with elastase-like molecules on the 
cell surface. 
Our main objective was to assess whether a T-cell-asso- 
ciated elastase could mediate mitogenesis; these results 
support a role in T-cell mitogenic signal transduction for a 
molecule which is antigenically related to elastase. The 
implication is that the latter is the binding protein and 
participates in signal transduction for the 45-kDa mitogen 
which we purified from a tumor cell line; this suggests a
previously undefined link in the immunosurveillance net- 
work between tumor cells and immunocytes. 
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